respiratory syncyti virus rev caps sever act lower tract disease lead number host death among infant elderly popup worldwide vaccine le effect drug avail infect natur infect stimuli th immune response active product neutral antibody earlier trial use uvinactiv exacerb due active allergy focus immune develop dna contain native fusion f protein studi basic mouse high level specify induce subset immune serum abl neutral vitro inhibit serum also shown immunofluoresc analyst antibody show strong immune infect reduce respect data revid active bias led desire require protect 